Results 151 to 160 of about 152,189 (278)
In this review, we summarize the current knowledge concerning the eukaryotic protozoan parasite Leishmania tarentolae, with a main focus on its potential for biotechnological applications.
Klatt, S.+3 more
core +1 more source
Leishmania Donovani; Partial Characterization of Some Flagellate Cytoplasmic Immunogens [PDF]
Bruce A. Clinton+2 more
openalex +1 more source
OBJECTIVE: Elevated serum levels of the acute-phase protein serum amyloid A (SAA) are a marker for active rheumatoid arthritis (RA), and SAA can also be found in the tissues of patients with active RA.
Björkman, Lena+5 more
core +1 more source
An Overview on Leishmania Diagnosis
Leishmaniasis is now accounted as a health problem and categorized as a class I disease (emerging and uncontrolled) by World Health Organization (WHO), causing highly significant morbidity and mortality with different clinical presentations.
Hossein Rezvan+2 more
doaj
Kinetoplast DNA: A Promising Drug Target for Treatment of Leishmaniasis
Leishmaniasis is a vector-borne zoonotic disease caused by various species of the genus Leishmania, (trypanosomatidae family) that is transmitted by phlebotomine sandflies.
Elham Kialashaki+4 more
doaj
Genetic control of natural resistance to Leishmania donovani (reply) [PDF]
PLANT, GLYNN
openalex +1 more source
Ninu Sharma, Myron Melamed
openaire +3 more sources
Evaluation of the Anti-Leishmanial Effect of Recombinant Clostridium α-Toxin
Fatemeh Namdar,1 Hossein Khanahmad,2 Zahra Ghayour,1 Farzaneh Mirzaei,3 Azam Namdar,4 Maryam Aghaei,5 Shahrokh Izadi,6 Faham Khamesipour,7,8 Seyed Hossein Hejazi1,9 1Department of Parasitology and Mycology, School of Medicine, Isfahan University of ...
Namdar F+8 more
doaj
CR1, the C3b receptor, mediates binding of infective Leishmania major metacyclic promastigotes to human macrophages. [PDF]
R P Da Silva+3 more
openalex +1 more source